Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Briones, Teresita L ^a   Darwish, Hala ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Aging; Cognitive aging; IL 10; IL 1 ; Learning and memory; Object recognition test

Indexed keywords

AMYLOID BETA PROTEIN; CALCITRIOL; INTERLEUKIN 10; INTERLEUKIN 1BETA;

AGE; AGED; AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; INFLAMMATION; LEARNING DISORDER; MALE; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 84867746110     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-244     Document Type: Article

References (37)

1. Coudray C, O'Connor JM, Maiani G, Cashman KD, Simpson EE, Secker DL, Ferry M, Roussel AM. Introduction to the ZENITH study and summary of baseline results. Eur J Clin Nutr 2005, 59(Suppl 2):S5-S7.
2. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW, Bowman BA. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002, 76:187-192.
3. Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care 2007, 10:12-19. 10.1097/MCO.0b013e328010ca18, 17143049.
4. Buell JS, Dawson-Hugues B. Vitamin D and neurocognitive dysfunction: preventing 'D'ecline?. Mol Aspects Med 2008, 29:415-422. 10.1016/j.mam.2008.05.001, 2829975, 18579197.
5. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005, 29:21-20. 10.1016/j.jchemneu.2004.08.006, 15589699.
6. Ramakrishna T. Vitamins and brain development. Physiol Res 1999, 48:175-187.
7. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D-3 and brain development. Neuroscience 2003, 118:641-653. 10.1016/S0306-4522(03)00040-X, 12710973.
8. de Abreu DA F, Nivet E, Baril N, Khrestchatisky M, Feron F. Developmental vitamin D deficiency alters learning in C57Bl/6J mice. Behav Brain Res 2010, 208:603-608. 10.1016/j.bbr.2010.01.005, 20079764.
9. Llewellyn DJ, Langa KM, Lang IA. Serum 25-hydroxyvitamin D concentration and mild cognitive impairment. J Geriatr Psychiatry Neurol 2009, 22:188-195. 10.1177/0891988708327888, 2730978, 19073839.
10. Oudshorn C, Mattace-Raso FUS, Van der Velde N, Colin EM, Van der Cammen TJM. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008, 25:539-543. 10.1159/000134382, 18503256.
11. Llewellyn DJ, Lang IA, Langa M, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci 2011, 66:59-65. 3011960, 21041201.
12. Annweiler C, Schott AM, Rolland Y, Blain H, Herrmann FR, Beauchet O. Dietary intake of vitamin D and cognition in older women: a large population-based study. Neurology 2010, 75:1810-1816. 10.1212/WNL.0b013e3181fd6352, 21079183.
13. Annweiler C, Fantino B, Schott AM, Krolak-Salmon P, Allali G, Beauchet O. Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol 2012, 19:1023-1029. 10.1111/j.1468-1331.2012.03675.x, 22339714.
14. Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, Beauchet O. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009, 6:1083-1089.
15. Buell JS, Scott TM, Dawson-Hughes B, Dallal GE, Rosenberg IH, Folstein MF, Tucker KL. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009, 64:888-895. 2981461, 19377013.
16. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P, Rosenberg IH, Folstein MF, Patz S, Bhadelia RA, Tucker KL. 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010, 74:18-26. 10.1212/WNL.0b013e3181beecb7, 2809024, 19940273.
17. Brown J, Bianco JI, McGrath JJ, Eyles DW. 1,25-dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 2003, 343:139-143. 10.1016/S0304-3940(03)00303-3, 12759183.
18. Dursun E, Gezen-Ak D, Yilmazer S. A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-beta and preventing the amyloid-beta induced alterations by vitamin D in cortical neurons. J Alzheimers Dis 2010, 23:207-219.
19. Jamilian H, Bagherzadeh K, Nazeri Z, Hassanijirdehi M. Vitamin D, parathyroid hormone, serum calcium and phosphorus in patients with schizophrenia and major depression. Int J Psychiatry Clin Pract 2012, PMID: 22536888.
20. Zhu Y, Zhou R, Yang R, Zhang Z, Bai Y, Chang F, Li L, Sokabe M, Goltzman D, Miao D, Chen L. Abnormal neurogenesis in the dentate gyrus of adult mice lacking 1,25dihydroxyvitamin D3 (1,25 (OH)2 D3). Hippocampus 2012, 22:421-433. 10.1002/hipo.20908, 21125584.
21. Alley DE, Crimmins EM, Karlamangla A, Hu P, Seeman TE. Inflammation and rate of cognitive change in high-functioning older adults. J Gerontol Series: A: Biol Sci Med Sci 2008, 63:50-55.
22. Bermejo P, Martin-Argon S, Benedi J, Susin C, Felici E, Gil P, Ribera JM, Villar AM. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. Immunol Lett 2008, 117:198-202. 10.1016/j.imlet.2008.02.002, 18367253.
23. Cunningham C. Systemic inflammation and delirium: important co-factors in the progression of dementia. Biochem Soc Trans 2011, 39:945-953. 10.1042/BST0390945, 21787328.
24. Gorelick PB. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci 2010, 1207:155-162. 10.1111/j.1749-6632.2010.05726.x, 20955439.
25. Briones TL, Woods J, Wadowska M, Rogozinska M. Amelioration of cognitive impairment and changes in microtubule-associated protein 2 after transient global cerebral ischemia are influenced by complex environment experience. Behav Brain Res 2006, 168:261-271. 10.1016/j.bbr.2005.11.015, 16356557.
26. Briones TL, Rogozinska M, Woods J. Environmental experience modulates ischemia-induced amyloidogenesis and enhances functional recovery. J Neurotrauma 2009, 24:613-625.
27. Barker GRI, Warburton EC. When is the hippocampus involved in recognition memory?. J Neurosci 2011, 31:10721-10731. 10.1523/JNEUROSCI.6413-10.2011, 21775615.
28. Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H. Hippocampal damage and exploratory preferences in rats: memory for objects, places, and context. Learn Mem 2002, 9:49-57. 10.1101/lm.41302, 155935, 11992015.
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
30. Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A. Vitamin D, nervous system and aging. Psychoneuroendocrinology 2009, 34S:S278-S286.
31. Cunningham C, Campion S, Lunnon K, Murray CL, Woods JF, Deacon RM, Rawlins JN, Perry VH. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative diseases. Biol Psychiatry 2009, 65:304-312. 10.1016/j.biopsych.2008.07.024, 2633437, 18801476.
32. Yu J, Gattoni-Celli M, Zhu H, Bhat NR, Sambamurti K, Gattoni-Celli S, Kindy MS. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice. J Alzheimers Dis 2011, 25:295-307.
33. McGeer E, McGeer P. Inflammatory cytokines in the CNS. CNS Drugs 1997, 7:214-287.
34. Apelt J, Schliebs R. Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res 2001, 892:21-30.
35. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, Dantzer R, Kelley KW. Interleukin-10 in the brain. Crit Rev Immunol 2001, 21:427-449.
36. Szczepanik AM, Ringheim GE. IL-10 and glucocoricoid inhibit Aβ(1-42)- and lipopolysacchiride-induced pro-inflammatory cytokine and chemokine induction in the central nervous system. J Alzheimers Dis 2003, 5:105-117.
37. Nalivaeva NN, Beckett C, Belyaev ND, Turner AJ. Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?. J Neurochem 2012, 120:167-185.